-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $12 Price Target

Benzinga·04/01/2025 12:14:39
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $12 price target.